COMMODORE CAPITAL LP
CIK 1831942 · last filed 2024-01-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$167.97M
Companies
4
Total Filings
18
Lifetime Open-Market Net
$6.38M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VERA | 10%+ Owner | 4,400,000 | $33.32 | $146.61M | -$12.10M | 2 | 2024-01-12 |
| VTGN | 10%+ Owner | 1,575,000 | $0.23 | $366.7K | $17.96M | 2 | 2023-10-06 |
| IMRA | 10%+ Owner | 1,448,640 | $14.49 | $20.99M | $177.2K | 2 | 2023-02-27 |
| Satsuma Pharmaceuticals, Inc. (STSA) Delisted | 10%+ Owner | 461,286 | $1.10 | $507.4K | $340.0K | 12 | 2022-11-16 |
Recent Filings · Page 2 of 2
18 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-10 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Buy (P) | +560 | $3.4K | EDGAR |
| 2021-11-08 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Buy (P) | +9,200 | $54.6K | EDGAR |
| 2021-11-04 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Buy (P) | +8,880 | $50.1K | EDGAR |
| 2021-11-02 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Buy (P) | +44,651 | $255.0K | EDGAR |
| 2021-10-29 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Buy (P) | +54,663 | $299.4K | EDGAR |
| 2021-10-25 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Buy (P) | +60,445 | $329.4K | EDGAR |
| 2021-10-21 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Buy (P) | +128,243 | $665.2K | EDGAR |
| 2021-10-19 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Buy (P) | +162,194 | $784.8K | EDGAR |
Showing 11–18 of 18
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.